MIRA INFORM REPORT

 

 

Report No. :

303704

Report Date :

24.01.2015

 

IDENTIFICATION DETAILS

 

Name :

TVPHARM PHARMACEUTICAL JSC

 

 

Formerly Known As :

TRA VINH PHARMACEUTICAL CO

 

 

Registered Office :

27 Dien Bien Phu St Ward 9, Tra Vinh, Tra Vinh

 

 

Country :

Vietnam

 

 

Financials (as on) :

2013

 

 

Date of Incorporation :

20.08.2010

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacturer of Medical Equipment and Pharmaceutical

 

 

No. of Employee :

600

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

Vietnam

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

VIETNAM - ECONOMIC OVERVIEW

 

Vietnam is a densely-populated developing country that has been transitioning from the rigidities of a centrally-planned economy since 1986. Vietnamese authorities have reaffirmed their commitment to economic modernization in recent years. Vietnam joined the World Trade Organization in January 2007, which has promoted more competitive, export-driven industries. Vietnam became an official negotiating partner in the Trans-Pacific Partnership trade agreement in 2010. Agriculture's share of economic output has continued to shrink from about 25% in 2000 to less than 20% in 2013, while industry's share increased from 36% to more than 42% in the same period. State-owned enterprises account for about 40% of GDP. Poverty has declined significantly, and Vietnam is working to create jobs to meet the challenge of a labor force that is growing by more than one million people every year. The global recession hurt Vietnam's export-oriented economy, with GDP in 2013 growing at 5%, the slowest rate of growth since 1999. In 2013, however, exports increased by more than 12%, year-on-year; several administrative actions brought the trade deficit back into balance. Between 2008 and 2011, Vietnam's managed currency, the dong, was devalued in excess of 20%, but its value remained relatively stable in 2013. Hanoi has oscillated between promoting growth and emphasizing macroeconomic stability in recent years. In February 2011, the government shifted from policies aimed at achieving a high rate of economic growth, which had stoked inflation, to those aimed at stabilizing the economy, through tighter monetary and fiscal control. Although Vietnam unveiled a broad, "three pillar" economic reform program in early 2012, proposing the restructuring of public investment, state-owned enterprises, and the banking sector, little perceptible progress has been made. Vietnam's economy continues to face challenges from an undercapitalized banking sector. Non-performing loans weigh heavily on banks and businesses.

 

Source : CIA

REGISTERED NAME AND COMPANY SUMMARY

 

Organization Name

:

TVPHARM PHARMACEUTICAL JSC (1)

Address

:

27 Dien Bien Phu St Ward 9, Tra Vinh, Tra Vinh

Country

:

Vietnam

Phone (S)

:

[+84] 74-3855371

Facsimile

:

[+84] 74-3740239

Email

:

info@tvpharm.com.vn

Website

:

http://www.tvpharm.com.vn

Primary Business Activity

:

Manufacturer

Key Industry

:

Medical Equipment & Pharmaceutical

Key Facts

Registered Legal Address

:

27 Dien Bien Phu St Ward 9, Tra Vinh, Tra Vinh

Operational Address

:

27 Dien Bien Phu St Ward 9, Tra Vinh, Tra Vinh

Trading Name

:

TVPHARM

Name History

:

Business Entity Name

Effective Date

TRA VINH PHARMACEUTICAL CO

11 Nov, 1992

TRA VINH PHARMACEUTICAL JSC

9 May, 2003

TVPHARM PHARMACEUTICAL JSC

6 Oct, 2006

Issuing Authority

:

Dept. of Planning & Investment - Tra Vinh

License Number

:

2100274872

License Status

:

License exists – Normal.

Legal Form - Category

:

Joint Stock Company

Legal Form

:

Joint Stock Company

Legal Form - Abbreviation

:

JSC

Operational Status of Business

:

Normal

Date of Registration

:

20 Aug, 2010

Employees

:

600

Capital

:

US$ 4,732,639

Note

:

Legal status of the English corporate name
The English name of the Subject Business Entity (SBE) is a randomly selected translation / transliteration made by the owners of the SBE. It is not a registered English corporate name, but simply a translation / transliteration of the local language name.

 

Report Details

 

Country

:

Vietnam

Business Entity Name

:

TVPHARM PHARMACEUTICAL JSC

Primary Business Activity

:

Manufacturer

Primary Industry

:

Medical Equipment & Pharmaceutical

Office Contact Details

Operating Address

:

27 Dien Bien Phu St Ward 9, Tra Vinh, Tra Vinh

Tel

:

[+84] 74-3855371

 

:

[+84] 74-3855372

 

:

[+84] 74-3740234

 

:

[+84] 74-3753121

Fax

:

[+84] 74-3740239

 

:

[+84] 74-3855372

Email

:

info@tvpharm.com.vn

Website Details

Website

:

http://www.tvpharm.com.vn

Status

:

Normal - operational

Country of Registration

:

Vietnam

Ownership Type

:

Registered ownership by Subject Business Entity

Tax / VAT Details

Tax Issuing Authority

:

Ministry of Finance

Local Name Used

:

Gia Trj Gia Tang (Value Added Tax)

Acronym

:

GTGT / VAT

GTGT / VAT Number

:

2100274872

 

 

DIRECTORS / MANAGEMENT

 

Key Person

 

Legal Title

:

Chairman

Name

:

Mr. Bui Van Tong

Nationality

:

Vietnamese

 

 

COMPANY MANAGEMENT

 

Management Listings

 

Name

Nationality

Job Description

Dept. / Division

1

Mr. Nguyen Dang Nguyen

Vietnamese

Managing Director

-

2

Mr. Nguyen Thanh Si

Vietnamese

Deputy Managing Director

-

3

Mr. Ha Van Dong

Vietnamese

Deputy Managing Director

-

4

Mr. Hoang Van Gioi

Vietnamese

Chief Accountant

Finance

 

Management Details - 1

Personal Unique Identifier

:

MI03814979

Name

:

Mr. Nguyen Dang Nguyen

 

Date of Birth

:

1960

 

Management Details - 2

Personal Unique Identifier

:

MI03815000

Name

:

Mr. Nguyen Thanh Si

 

Date of Birth

:

1967

 

Management Details - 3

Personal Unique Identifier

:

MI03815015

Name

:

Mr. Ha Van Dong

 

Date of Birth

:

1966

 

Management Details - 4

Personal Unique Identifier

:

MI03815082

Name

:

Mr. Hoang Van Gioi

 

Date of Birth

:

1952

 

 

COMPANY DIRECTORS

 

1

 

 

Personal Unique Identifier

:

MI03814981

Name

:

Mr. Bui Van Tong

Date of Birth

:

1965

 

2

 

 

Personal Unique Identifier

:

MI03814979

Name

:

Mr. Nguyen Dang Nguyen

Date of Birth

:

1960

 

 

NEGATIVE INFORMATION

 

REPUTATION

Reference checking for the purpose of establishing TVPHARM PHARMACEUTICAL JSC's reputation within the respective industry failed to reveal any adverse information.

 

NEGA-SCAN - ADVERSE DATA MONITORING

 

DISHONORED CHECKS

 

No Record Found

 

 

DEBT

 

No Record Found

 

 

CIVIL LITIGATION

 

No Record Found

 

 

PERFORMANCE DEFAULTS

 

No Record Found

 

 

ADVERSE LOCAL MEDIA COVERAGE / ADVERSE FILING HISTORY

 

No Record Found

 

 

 

 

SHARE and SHARE CAPITAL INFORMATION

 

CAPITAL (Currency: VND - Vietnam Dong)

 

Authorized Capital

:

₫ 100,800,000,000

Date

Authorized Capital - History

11 Nov, 1992

63,000,000,000

2013

100,800,000,000

 

 

SHAREHOLDERS

 

Total number of shareholders

:

n/a

Total number of shares

:

n/a

 

 

Currency

:

VND - Vietnam Dong

 

 

No.

Shareholders

Country

Shares

Number

Amount (VND)

%

1

STATE CAPITAL INVESTMENT CORP

Vietnam

n/a

n/a

n/a

2

Undisclosed Shareholders

n/a

n/a

n/a

n/a

Total

n/a

n/a

n/a

 

 

 

Based on corporate statutory laws / regulations in Vietnam, there is no requirement for public disclosure of Shareholders. In this case, the Shareholders information was supplied by the Subject Business Entity.
However in the absence of data normally obtained from local Statutory Authorities, it is not possible to verify the accuracy of data supplied and hence is provided as reference ONLY.

 

 

PAYMENT INFORMATION

 

Primary Products

Products / Materials / Services Description

Activity

Analgesics

Manufacturing, Exporting

Anti-diabetics

Manufacturing, Exporting

Anti-inflammatory

Manufacturing, Exporting

Antibiotics

Manufacturing, Exporting

Antihistamine

Manufacturing, Exporting

 

 

 

International Trade - Statistics  (Currency: USD - US Dollar)

Year

Imports

Exports

Total

2011

n/a

1,608,003

1,608,003

2012

n/a

1,963,254

1,963,254

2013

n/a

1,996,781

1,996,781

 

DOMESTIC SALES and PURCHASES

 

Annual Sales Analysis

Percentage

Domestic Sales

90%

International Sales (Export)

10%

Annual Purchases Analysis

Percentage

Local Purchases

20%

Imports

80%

 

 

PAYMENT TERMS

 

Selling

 

Type

Terms

Local

Cash on delivery (COD)

Credit - Unsecured 30~90 days

Export

Letter of Credit (At-sight)

Telegraphic Transfer (T/T) - Received at time of transaction

 

Purchasing

Type

Terms

Local

Cash on delivery (COD)

Credit - Unsecured 30~90 days

Import

Letter of Credit (At-sight)

Telegraphic Transfer (T/T) - Executed at time of transaction

 


 

FINANCIAL INFORMATION

 

Financials - Summary  (Currency: USD - US Dollar)

Year

Sales

Assets

Net Income

2011 Annual

16,080,029

10,985,406

1,388,766

2012 Annual

19,632,541

14,426,550

2,470,004

2013 Annual (*)

19,967,811

14,940,234

1,715,708

 

Sales Trend – Analysis

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

-

-

-

-

-

-

-

-

http://www.asiancredit.com/Manage/image/up_arrow_04.gif

http://www.asiancredit.com/Manage/image/up_arrow_04.gif

Note: (*)

Financials listed are the most recent available for this company.

 

 

FINANCIAL STATEMENT – DETAILED

 

Balance Sheet

Currency

:

VND

Denomination

:

1

Financial Year Ending

:

December

 

Financial Highlights

2011 Annual

2012 Annual

2013 Annual

Current Assets(*)

182,846,000,000

257,182,000,000

262,290,000,000

Non Current Assets(*)

45,980,000,000

43,246,000,000

52,771,000,000

Non Current Liabilities(*)

1,388,000,000

5,988,000,000

5,893,000,000

Share Capital(*)

63,000,000,000

63,000,000,000

100,800,000,000

Other long term assets 

Total Assets(*)

228,826,000,000

300,428,000,000

315,061,000,000

Total Liabilities(*)

87,577,000,000

128,797,000,000

138,719,000,000

Current Liabilities(*)

86,189,000,000

122,809,000,000

132,826,000,000

Long term liabilities 

Shareholders Funds(*)

141,249,000,000

171,631,000,000

176,342,000,000

 

Current assets & short term investments

182,846,000,000

257,182,000,000

262,290,000,000

Cash & cash equivalents

29,083,000,000

24,396,000,000

13,591,000,000

Cash

29,083,000,000

24,396,000,000

13,591,000,000

Accounts receivable

75,155,000,000

125,305,000,000

125,813,000,000

Accounts receivable trade

79,754,000,000

124,581,000,000

126,460,000,000

Trade prepayment

879,000,000

2,998,000,000

3,478,000,000

Others receivables

928,000,000

1,034,000,000

696,000,000

Provision for bad debts

(6,406,000,000)

(3,308,000,000)

(4,821,000,000)

Inventories

69,103,000,000

96,912,000,000

115,567,000,000

Other short term asset

9,505,000,000

10,569,000,000

7,319,000,000

Prepaid expenses

137,000,000

72,000,000

512,000,000

VAT deductible

242,000,000

248,000,000

845,000,000

Other tax receivables

-

-

65,000,000

i. Other short term asset

9,126,000,000

10,249,000,000

5,897,000,000

Long term assets

45,980,000,000

43,246,000,000

52,771,000,000

Accounts of long term receivable

-

50,000,000

50,000,000

Other long term receivables

-

50,000,000

50,000,000

Fixed assets

45,286,000,000

42,332,000,000

52,300,000,000

Tangible fixed assets

35,330,000,000

32,623,000,000

36,298,000,000

Cost

95,162,000,000

98,734,000,000

105,729,000,000

Accumulated depreciation

59,832,000,000

66,111,000,000

69,431,000,000

Intangible fixed assets

9,956,000,000

9,702,000,000

9,532,000,000

i. Cost

11,346,000,000

11,346,000,000

11,434,000,000

i. Accumulated depreciation

1,390,000,000

1,644,000,000

1,902,000,000

Construction in progress

-

7,000,000

6,470,000,000

Other long term assets

694,000,000

864,000,000

421,000,000

Long term prepayments

694,000,000

864,000,000

421,000,000

Total assets

228,826,000,000

300,428,000,000

315,061,000,000

Liabilities

87,577,000,000

128,797,000,000

138,719,000,000

Current liabilities

86,189,000,000

122,809,000,000

132,826,000,000

Short term borrowings

40,578,000,000

51,068,000,000

53,088,000,000

Accounts payables-trade

31,867,000,000

49,283,000,000

42,568,000,000

Advances from customers

35,000,000

249,000,000

84,000,000

Taxes and payable to state budget

3,802,000,000

4,505,000,000

9,141,000,000

Payable to employees

6,608,000,000

11,595,000,000

8,256,000,000

Accrued expenses payable

2,497,000,000

5,115,000,000

13,667,000,000

Other payables

802,000,000

840,000,000

4,497,000,000

Bonus and welfare funds

-

154,000,000

1,525,000,000

Long term liabilities

1,388,000,000

5,988,000,000

5,893,000,000

Long term other payables

300,000,000

305,000,000

311,000,000

Provision funds for unemployment

517,000,000

5,209,000,000

5,582,000,000

Provision for long term payable

571,000,000

-

-

Deffered revenue

-

474,000,000

-

Owners' equity

141,249,000,000

171,631,000,000

176,342,000,000

Business capital

63,000,000,000

63,000,000,000

100,800,000,000

Share capitals' surplus

34,563,000,000

34,563,000,000

3,063,000,000

Shares

-

-

(2,000,000)

Foreign exchange differences

444,000,000

-

-

Business development funds

15,711,000,000

20,439,000,000

35,870,000,000

Financial reserved funds

5,823,000,000

6,300,000,000

6,300,000,000

Retained earnings

22,469,000,000

47,329,000,000

30,311,000,000

Budget sources

(761,000,000)

-

-

i. Bonus and welfare funds

(761,000,000)

-

-

Minority Interest 

Total resources

228,826,000,000

300,428,000,000

315,061,000,000

Note: (*)

Financial Highlights

 

Income Statement

 

Currency

:

VND

Denomination

:

1

Financial Year Ending

:

December

 

 

 

Financial Highlights

2011 Annual

2012 Annual

2013 Annual

Turnover(*)

334,947,000,000

408,841,000,000

421,083,000,000

Profit (Loss) Before Tax(*)

37,013,000,000

64,884,000,000

51,009,000,000

Profit After Tax attributable to Shareholders(*)

28,928,000,000

51,437,000,000

36,181,000,000

 

Gross sales

334,947,000,000

408,841,000,000

421,083,000,000

Less deductions

3,987,000,000

3,492,000,000

3,284,000,000

Net income

330,960,000,000

405,349,000,000

417,799,000,000

Cost of goods sold

210,361,000,000

245,802,000,000

252,152,000,000

Gross margin

120,599,000,000

159,547,000,000

165,647,000,000

Income from financial activities

4,636,000,000

4,076,000,000

2,298,000,000

Expenses from financial activities

12,959,000,000

7,669,000,000

9,283,000,000

In which: Interest expenses

7,320,000,000

5,450,000,000

5,452,000,000

Selling expenses

59,838,000,000

71,517,000,000

83,778,000,000

General & administration expenses

15,776,000,000

21,074,000,000

24,949,000,000

Net income from operating activities

36,662,000,000

63,363,000,000

49,935,000,000

Extraordinary income

646,000,000

1,667,000,000

1,118,000,000

Extraordinary expenses

295,000,000

146,000,000

44,000,000

Extraordinary gains

351,000,000

1,521,000,000

1,074,000,000

Net profit before tax

37,013,000,000

64,884,000,000

51,009,000,000

Income tax

8,085,000,000

13,447,000,000

14,828,000,000

Net profit after tax

28,928,000,000

51,437,000,000

36,181,000,000

Note: (*)

Financial Highlights

 

Financial Ratios

Financial Highlights

2011 Annual

2012 Annual

2013 Annual

Growth % 

Year-on-Year Growth

-

22.06

2.99

Profitability 

Profit Margin (%)

8.64

12.58

8.59

Return on Equity (%)

20.48

29.97

20.52

Return on Assets (%)

12.64

17.12

11.48

Leverage 

Total Debt Equity (Times)

0.62

0.75

0.79

Current Debt Equity (Times)

0.61

0.72

0.75

Long Term Debt to Equity

0.01

0.03

0.03

Total Asset To Total Equity

1.62

1.75

1.79

Asset Management 

Total Assets Turnover (Times)

1.46

1.36

1.34

Fixed Assets Turnover (Times)

7.28

9.45

7.98

Liquidity 

Current Ratio

2.12

2.09

1.97

Based on the corporate laws of Vietnam, legal entities which are Joint Stock Company are not required to make public disclosure of their annual financials. Although basic financials were obtained for reference.

 

 

FOREIGN EXCHANGE RATES

 

Today's Exchange rate

:

1.00 VND
Vietnam Dong

=

0.000047 USD
United States Dollars

 

 

ADDITIONAL INFORMATION

 

SIC PRODUCT CLASSIFICATION & ACTIVITY

Product/Service Description

Code

Activity

Medical/Dental Equip/Supplies

5047

Manufacturing, Exporting

Orthopedic, prosthetic, and surgical appliances and supplies, nspf

3842

Manufacturing, Exporting

Pharmaceutical preparations

2834

Manufacturing, Exporting

 

HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY

Product/Service Description

Code

Activity

Analgesics, antipyretics and nonhormonal anti-inflammatory agents

3004906025

Manufacturing, Exporting

Antibiotics

2941

Manufacturing, Exporting

Cardiovascular medicaments nesoi

3004909020

Manufacturing, Exporting

Medicaments nesoi, mixed or not, in dosage etc form

3004

Manufacturing, Exporting

Medicaments primarily affecting the eyes, ears or respiratory system

3004400060

Manufacturing, Exporting

Pharmaceutical products

3000

Manufacturing, Exporting

Provitamins and vitamins & derivatives & intermixs

2936

Manufacturing, Exporting

 

DETAILED PRODUCT CLASSIFICATION & ACTIVITY

Products / Materials / Services Description

Ranking

Activity

Antipyretic

Primary

Manufacturing, Exporting

Cardiovascular agents

Primary

Manufacturing, Exporting

Gastrointestinal

Primary

Manufacturing, Exporting

Nutrition

Primary

Manufacturing, Exporting

Pharmaceutical products

Primary

Manufacturing, Exporting

Respiratory agents

Primary

Manufacturing, Exporting

Vitamins

Primary

Manufacturing, Exporting

 

CORE BUSINESS DESCRIPTION

 

Core Business

 

The primary business focus of TVPHARM PHARMACEUTICAL JSC is Manufacturing - Finished products.

Key products include :

  • Anti-diabetics
  • Anti-inflammatory
  • Antibiotics
  • Antihistamine
  • Antipyretic
  • Cardiovascular agents
  • Gastrointestinal
  • Nutrition
  • Pharmaceutical products
  • Respiratory agents
  • Vitamins


An integral part of the core business includes:

 

  • Distribution

 

Supplementary Business

 

In addition to the core business, TVPHARM PHARMACEUTICAL JSC also is engaged in the following areas of business:

Exporting

  • Exporting - Finished products

Importing

  • Importing - Raw materials

 

 

BANK DETAILS

Bank Name

:

JOINT STOCK COMMERCIAL BANK FOR INVESTMENT & DEVELOPMENT OF VIETNAM

Global Identifier

:

32400483

Branch

:

Hoan Kiem Dist,Hanoi

Branch Address

:

JOINT STOCK COMMERCIAL BANK FOR INVESTMENT AND DEVELOPMENT OF VIETNAM - TRA VINH DIST, TRA VINH

SWIFT Code

:

BIDVVNVX

 

Bank Name

:

VIETNAM JOINT STOCK COMMERCIAL BANK FOR INDUSTRY & TRADE

Global Identifier

:

32404058

Branch

:

Hoan Kiem Dist,Hanoi

Branch Address

:

VIETNAM JOINT STOCK COMMERCIAL BANK FOR INDUSTRY AND TRADE - TRA VINH, TRA VINH

SWIFT Code

:

ICBVVNVX

 

 

LOCAL BRANCHES And MANAGEMENT

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - TRA VINH, TRA VINH

Branch Address

:

37-39 Pham Thai Buong St Ward 3, Tra Vinh, Tra Vinh

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - BIEN HOA, DONG NAI

Branch Address

:

20/4 CMT8 Quang Vinh Ward, Bien Hoa, Dong Nai

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - LONG XUYEN, AN GIANG

Branch Address

:

11B Bui Thi Xuan My Xuyen Ward, Long Xuyen, An Giang

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - BUON ME THUOT, DAK LAK

Branch Address

:

A8 Khu Hiep Phuc Tan Loi Ward, Buon Me Thuot, Dak Lak

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - HAI CHAU DIST, DA NANG

Branch Address

:

423 Trung Nu Vuong St Hoa Thuan Tay Ward, Hai Chau Dist, Da Nang

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - BIEN HOA, DONG NAI

Branch Address

:

20/4 KP3 CMT8 Quang Vinh Ward, Bien Hoa, Dong Nai

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - NHA TRANG, KHANH HOA

Branch Address

:

Lot 29 Rd B1 KDT Vinh Diem Trung, Nha Trang, Khanh Hoa

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - DISTRICT 10, HO CHI MINH

Branch Address

:

Q1A Bach Ma CX Bac Hai Ward 15, District 10, Ho Chi Minh

Branch Tel

:

84-8-39702315

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - CAN THO

Branch Address

:

17/B2 KDC 91B An Khanh Ward, Can Tho

 

Branch

:

TVPHARM PHARMACEUTICAL JSC - CAU GIAY DIST, HANOI

Branch Address

:

Trung Hoa Ward 22 Lot 11B Trung Yen 10 KDT Trung Yen, Cau Giay Dist, Hanoi

 

 

INTERNATIONAL TRADE – Activity and Markets

 

 

Country / Region

Estimated level of importance

Trading Activity

Asia / Pacific

Medium

Importing, Exporting

Europe

Medium

Importing

North America

Medium

Importing

Cambodia

Medium

Exporting

China

Medium

Importing

France

Medium

Importing

Germany

Medium

Importing

India

Medium

Importing

Laos

Medium

Exporting

USA

Medium

Importing

 

 

OFFICE and FACILITIES

 

The following information relates to the Business Entity's office as listed above:

 

Name

:

TVPHARM PHARMACEUTICAL JSC - TRA VINH, TRA VINH

Primary Use

:

Office & Administration facilities

Building Size

:

30,000 Square meters

Address

:

27 Dien Bien Phu St Ward 9, Tra Vinh, Tra Vinh

Country

:

Vietnam

Ownership of Property

:

Rented / Leased

Status

:

Operational

 

 

COMPANY HISTORY

 

Date

Details

2003 - May

Changed its legal structure from Government Enterprise to Joint Stock Company.

 

 

AWARDS

 

#

Award Name

Awarded by

Awarded Date

1

Gold Cup ISO 2007

MINISTRY OF SCIENCE AND TECHNOLOGY CERTIFICATION

n/a

2

Hero of Labor Reform Era

PRESIDENT

n/a

 

 

 

QUALITY ACCREDITATION

 

Quality Accreditation Listings

#

Name

Accreditation Category

1

INTERNATIONAL STANDARDS ORGANIZATION (ISO)

9001:2000

2

GOOD MANUFACTURING PRACTICE (GMP)

-

 

 

PREVIOUS BUSINESS LICENSE/S

License Date

License No.

11 Nov, 1992

101956

9 May, 2003

5803000005


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.50

UK Pound

1

Rs. 92.16

Euro

1

Rs. 69.62

 

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

ASH

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.